GTEx Uterus 20-29 vs 40-49 Up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GTEx Uterus 20-29 vs 40-49 Up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GTEx Uterus 20-29 vs 40-49 Up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GTEx Uterus 20-29 vs 40-49 Up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GTEx Uterus 20-29 vs 40-49 Up.

Results found

Linked to

 

Label

Description

 

Gene

long intergenic non-protein coding RNA 1291

Gene

p53 upregulated regulator of p53 levels

Gene

long intergenic non-protein coding RNA 1133

Gene

ubiquitin specific peptidase 32 pseudogene 1

Gene

CDKN2B and CDKN2A antisense cis and trans regulatory RNA 1

Gene

MT-ND1 pseudogene 23

Gene

MIR205 host gene

Gene

long intergenic non-protein coding RNA 1638

Gene

TGF-beta induced lncRNA

Gene

ribosomal protein SA pseudogene 53

  • Gene

    long intergenic non-protein coding RNA 1291


  • Gene

    p53 upregulated regulator of p53 levels


  • Gene

    long intergenic non-protein coding RNA 1133


  • Gene

    ubiquitin specific peptidase 32 pseudogene 1


  • Gene

    CDKN2B and CDKN2A antisense cis and trans regulatory RNA 1


  • Gene

    MT-ND1 pseudogene 23



  • Gene

    long intergenic non-protein coding RNA 1638


  • Gene

    TGF-beta induced lncRNA


  • Gene

    ribosomal protein SA pseudogene 53

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.